Skip to main content

COVID-19 and impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

New special issue: Translating the microbiome

Our special issue on ‘Translating the microbiome in health and disease’, guest edited by Ramnik Xavier has now launched.

SARS-CoV-2 vaccine targets

Asaf Poran and colleagues provide a comprehensive set of CD4+ and CD8+ T cell epitopes spanning the entire SARS-CoV-2 genome.

Plasma ctDNA and prostate cancer

Niall Corcoran and colleagues show that detection of ctDNA in patients with prostate cancer before surgery is associated with lower metastasis-free survival.

Strain-level epidemiology of microbial communities

Curtis Huttenhower and colleagues discuss our current knowledge of microbiome strains in the human body and their links to health and disease. 

Reviews, Research Highlights and Commentaries

Read authoritative Reviews, Opinions and other content commissioned by the Genome Medicine Editors from leading researchers:


Research Highlights

Commentaries (including Editorials, Comments, Opinions, Q&As and Meeting reports)


Focus: Pathogens

Read the latest papers on pathogens, disease and diagnostics across BMC flagship journals.

Evaluation of the potential incidence of COVID-19 and effectiveness of containment measures in Spain: a data-driven approach
Alberto Aleta and Yamir Moreno​​​​​​​

Published in BMC Medicine 27 May 2020

MARPLE, a point-of-care, strain-level disease diagnostics and surveillance tool for complex fungal pathogens​​​​​​​
Guru Radhakrishnan​​​​​​​ et al.

Published in BMC Biology 13 August 2019

Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential
Kara A. Moser​​​​​​​ et al.

Published in Genome Medicine 08 January 2020

SEPATH: benchmarking the search for pathogens in human tissue whole genome sequence data leads to template pipelines​​​​​​​
Abraham Gihawi​​​​​​​ et al.

Published in Genome Biology 22 October 2019

Aims and scope

Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries. 

Article collections

Special issue
Clinical interpretation of genome variation
Guest editors: Heidi Rehm and Douglas Fowler

A decade of Genome Medicine

Special issue
Tumor immune microenvironment and immunotherapy
Guest editors: Zlatko Trajanoski and Noel de Miranda

Special issue
From genome integrity to cancer
Guest editor: Serena Nik-Zainal

See all article collections

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

  • Editorial Board
  • Editorial Team
  • Sign up for article alerts and news from this journal
  • Contact us
  • Announcements

    C19 Rapid Review Initiative

    Genome Medicine has joined the C19 Rapid Review Initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here

    Submissions from medRxiv 

    Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.

    Portable peer review

    To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.

    COVID-19 submissions

    In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.